KMKi Mark Mak

Ki Mark Mak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ki Mark Mak has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Dietary nutrients and biotics protect against injury to intestinal epithelial barrier in alcohol use disorder: A narrative review

    by Ki M. Mak, Aditya C. Shekhar

    The intestinal epithelial barrier is anatomically and functionally distinct and specifically refers to the barrier formed by epithelial cells (enterocytes) and associated junctional complexes (tight junctions, adherens junctions, and desmosomes). The junctional complex is composed of specialized junctional proteins that regulate nutrient permeability across the gut epithelium while preventing passage of antigens, bacteria, and toxins. Modifying the junctional protein expression and disrupting the junctional complex structure result in intestinal hyperpermeability, referred to as “leaky gut.” The leakiness promotes endotoxemia and systemic inflammation, which orchestrate metabolic diseases of multiple organs, notably the liver. Ethanol and its metabolite acetaldehyde, bacterial lipopolysaccharide (LPS), and neutrophil extracellular traps (NETs) deliver a four‐pronged attack disrupting the gut epithelial barrier in alcohol use disorder (AUD). This article reviews the benefits of protecting the gut epithelial barrier structure and function in AUD. Adequate nutritional support is essential for maintaining the barrier integrity and sustaining gut health. Dietary nutrients and biotics supplements are effective in reinforcing the gut epithelial barrier integrity. Accordingly, this article elaborates on the prominent roles of dietary zinc, glutamine, and vitamin D supplementation in modulating the gut barrier junctional protein expression while mitigating the epithelial barrier breakdown induced by ethanol, acetaldehyde, LPS, and NETs. The efficacy of prebiotics, probiotics, and postbiotics in preventing disruption of the gut epithelial barrier in AUD is also reviewed. In summary, dietary nutrients and biotics supplements are beneficial in preserving the gut epithelial barrier integrity in AUD, thereby offering a supportive treatment option for alcohol‐related diseases.

  • Ethanol, acetaldehyde, lipopolysaccharide, and neutrophil extracellular traps: four‐pronged attack on gut epithelial barrier in alcohol use disorder

    by Ki M. Mak, Selena Y. Ding, Charu Jain

    The intestinal epithelial barrier is formed by epithelial cells and their associated junctional complexes, comprising tight junctions, adherens junctions, and desmosomes. The junctional complex is composed of specialized junctional proteins that regulate nutrient permeability across the gut epithelium, while preventing penetration of pathogenic bacteria and toxins. Disruption of the junctional complex integrity and tampering with the junctional protein function lead to intestinal hyperpermeability, a phenomenon known as “leaky gut.” This leakiness results in endotoxemia and systemic inflammation, which together orchestrate metabolic diseases of multiple organs, notably fatty liver and hepatitis, obesity, diabetes, cardiovascular lesions, renal disease, and CNS disorders. This article reviews the molecular and signaling mechanisms by which ethanol and its metabolite acetaldehyde, and bacterial lipopolysaccharide downregulate and redistribute the junctional proteins, thereby compromising the gut epithelial barrier function resulting in hyperpermeability. These data are gathered from investigations with patients with alcohol use disorder, alcohol‐fed animals, and intestinal cell culture models. The review also covers the emerging role of neutrophil‐derived neutrophil extracellular traps in executing the pathophysiology of the intestinal epithelial barrier in conditions of intestinal inflammation associated with alcohol consumption, experimental intestinal injury, colitis, and inflammatory bowel diseases, enteric nutrition, and diabetes. Thus, adequate nutritional support is essential for sustaining gut health and maintaining the barrier function. When the gut barrier is compromised, the intestine becomes a “portal”, leading to systemic metabolic disease pathogenesis.


  • Neutrophil extracellular traps mediate pathophysiology of hepatic cells during liver injury

    by Ki M. Mak, Aditya C. Shekhar, Selena Y. Ding

    Neutrophil extracellular traps (NETs) are web‐like, bactericidal structures produced by neutrophils and are composed principally of extracellular DNA, histones, elastase, and myeloperoxidase, among other components. NET formation is an innate immune response that is beneficial for pathogen killing and clearance. However, excessive NET formation and clearance defects can lead to inflammation and induce damage to host organs. NETs are also implicated in the development of noninfectious inflammatory disorders, such as liver injury in chronic liver diseases. The liver parenchyma contains hepatocytes, liver sinusoidal endothelial cells, Kupffer cells, and hepatic stellate cells. Each of these cells possesses unique structures and functions, and their interactions with NETs result in pathophysiological changes contributing to liver injury. This review updates the findings related to the modes of action and molecular mechanisms by which NETs modulate the pathophysiology of various hepatic cells and potentiate liver injury. The article also reviews the roles of NETs in hepatic ischemia reperfusion injury, hepatocellular carcinoma pathogenesis, and cancer metastasis. Last, we examine data to determine whether NETs induce crosstalk among various hepatic cells during liver injury and to identify future research directions.


  • Lipopolysaccharide, arbiter of the gut–liver axis, modulates hepatic cell pathophysiology in alcoholism

    by Ki M. Mak, Aditya C. Shekhar

    Over the last four decades, clinical research and experimental studies have established that lipopolysaccharide (LPS)—a component of the outer membrane of gram‐negative bacteria—is a potent hepatotoxic molecule in humans and animals. Alcohol abuse is commonly associated with LPS endotoxemia. This review highlights LPS molecular structures and modes of release from bacteria, plasma LPS concentrations, induction of microbiota dysbiosis, disruption of gut epithelial barrier, and translocation of LPS into the portal circulation impacting the pathophysiology of hepatic cells via the gut‐liver axis. We describe and illustrate the portal vein circulation and its distributaries draining the gastrointestinal tract. We also elaborate on the gut‐liver axis coupled with enterohepatic circulation that represents a bidirectional communication between the gut and liver. The review also updates the data on how circulating LPS is cleared in a coordinated effort between Kupffer cells, hepatocytes, and liver sinusoidal endothelial cells. Significantly, the article reviews and updates the modes/mechanisms of action by which LPS mediates the diverse pathophysiology of Kupffer cells, hepatocytes, sinusoidal endothelial cells, and hepatic stellate cells primarily in association with alcohol consumption. Specifically, we review the intricate linkages between ethanol, microbiota dysbiosis, LPS production, gut‐liver axis, and pathophysiology of various hepatic cells. The maintenance of the gut barrier structural and functional integrity and microbiome homeostasis is essential in mitigating alcoholic liver disease and improving liver health.


  • Soybean polyenylphosphatidylcholine (PPC) is beneficial in liver and extrahepatic tissue injury: An update in experimental research

    by Ki M. Mak, Aditya C. Shekhar

    Polyenylphosphatidylcholine (PPC) is a purified polyunsaturated phosphatidylcholine extract of soybeans. This article updates PPC's beneficial effects on various forms of liver cell injury and other tissues in experimental research. PPC downregulates hepatocyte CYP2E1 expression and associated hepatotoxicity, as well as attenuates oxidative stress, apoptosis, lipoprotein oxidation and steatosis in alcoholic and nonalcoholic liver injury. PPC inhibits pro‐inflammatory cytokine production, while stimulating anti‐inflammatory cytokine secretion in ethanol or lipopolysaccharide‐stimulated Kupffer cells/macrophages. It promotes M2‐type macrophage polarization and metabolic reprogramming of glucose and lipid metabolism. PPC mitigates steatosis in NAFLD through inhibiting polarization of pro‐inflammatory M1‐type Kupffer cells, alleviating metabolic inflammation, remodeling hepatic lipid metabolism, correcting imbalances between lipogenesis and lipolysis and enhancing lipoprotein secretion from hepatocytes. PPC is antifibrotic by preventing progression of alcoholic hepatic fibrosis in baboons and also prevents CCl4‐induced fibrosis in rats. PPC supplementation replenishes the phosphatidylcholine content of damaged cell membranes, resulting in increased membrane fluidity and functioning. Phosphatidylcholine repletion prevents increased membrane curvature of the endoplasmic reticulum and Golgi and decreases sterol regulatory element binding protein‐1‐mediated lipogenesis, reducing steatosis. PPC remodels gut microbiota and affects hepatic lipid metabolism via the gut‐hepatic‐axis and also alleviates brain inflammatory responses and cognitive impairment via the gut‐brain‐axis. Additionally, PPC protects extrahepatic tissues from injury caused by various toxic compounds by reducing oxidative stress, inflammation, and membrane damage. It also stimulates liver regeneration, enhances sensitivity of cancer cells to radiotherapy/chemotherapy, and inhibits experimental hepatocarcinogenesis. PPC's beneficial effects justify it as a supportive treatment of liver disease.


  • A review of hepatic fibrosis‐associated histopathology in aged cadavers

    by Ki M. Mak, Dustin Kee, Christopher P. Cheng

    This article reviews hepatic fibrosis‐associated histopathology of aged cadavers (mean age 82 years). A study of 68 livers identified steatosis in 35.5%, central vein fibrosis in 49.2%, perisinusoidal fibrosis in 63.2%, portal tract fibrosis in 47.7%, septa formation in 44.1%, bridging fibrosis in 30.8%, and cirrhosis in 4.4% of the samples as well as one hepatocellular carcinoma and six metastatic tumors. Other studies have revealed that collagens I, III, IV, V, and VI and fibronectin constitute the matrices of fibrous central veins, perisinusoidal space, portal tracts, and septa. Elastin is rich in portal tracts and fibrous septa but absent from the perisinusoidal space. Hepatic stellate cells are ubiquitous in the liver parenchyma while myofibroblasts localize in fibrotic foci. Factor VIII‐related antigen expression signals sinusoidal to systemic vascular endothelium transformation while collagen IV and laminin codistribution indicates formation of perisinusoidal membranes. Their coincidence reflects focalized capillarization of sinusoids in the aged liver. In response to fibrogenesis, hepatic progenitor cells residing in the canal of Hering in the periportal parenchyma undergo expansion and migration deep into the lobule. Concomitantly, intermediate hepatocyte‐like cells increase in advanced fibrosis stages, which is possibly related to hepatic regeneration. Metabolic zonation of glutamine synthetase expands from the perivenous to non‐perivenous parenchyma in fibrosis progression but its expression is lost in cirrhosis, while cytochrome P‐4502E1 expression is maintained in centrilobular and midlobular zones in fibrosis progression and expressed in cirrhosis. Hence, cadaveric livers provide a platform for further investigation of hepatic histopathologies associated with the aging liver.


  • Alcohol‐associated capillarization of sinusoids: A critique since the discovery by Schaffner and Popper in 1963

    by Ki M. Mak, Dustin Kee, Da Wi Shin

    This article reviews the literature on capillarization of hepatic sinusoids since its discovery in 1963. Liver sinusoidal endothelial cells are uniquely fenestrated and lack an underlying basement membrane. In chronic liver disease, the sinusoids capillarize and transform into systemic capillaries, a process termed capillarization of sinusoids. The histopathology is marked by defenestration, basement membrane formation, and space of Disse fibrogenesis. Capillarized sinusoids compromise the bidirectional exchange of materials between sinusoids and hepatocytes, leading to hepatocellular dysfunction. Sinusoidal capillarization was first described in active cirrhosis of alcoholics in 1963. Since then, it has been found in early and progressive stages of alcoholic hepatic fibrosis before the onset of cirrhosis. The sinusoidal structure is not altered in alcoholic steatosis without fibrosis. Defenestration impairs the ability of the endothelium to filter chylomicron remnants from sinusoids into the Disse's space, contributing to alcohol‐induced postprandial hyperlipidemia and possibly atherosclerosis. Ethanol also modulates the fenestration dynamics in animals. In baboons, chronic alcohol consumption diminishes endothelial porosity in concomitance with hepatic fibrogenesis and in rats defenestrates the endothelium in the absence of fibrosis, and sometimes capillarizes the sinusoids. Acute ethanol ingestion enlarges fenestrations in rats and contracts fenestrations in rabbits. In sinusoidal endothelial cell culture, ethanol elicits fenestration dilation, which is likely related to its interaction with fenestration‐associated cytoskeleton. Ethanol potentiates sinusoidal injury caused by cocaine, acetaminophen or lipopolysaccharide in mice and rats. Understanding ethanol's mechanisms on pathogenesis of sinusoidal capillarization and fenestration dynamics will lead to development of methods to prevent risks for atherosclerosis in alcoholism.


  • Hepatic sinusoids versus central veins: Structures, markers, angiocrines, and roles in liver regeneration and homeostasis

    by Ki M. Mak, Da Wi Shin

    The blood circulates through the hepatic sinusoids delivering nutrients and oxygen to the liver parenchyma and drains into the hepatic central vein, yet the structures and phenotypes of these vessels are distinctively different. Sinusoidal endothelial cells are uniquely fenestrated, lack basal lamina and possess organelles involved in endocytosis, pinocytosis, degradation, synthesis and secretion. Hepatic central veins are nonfenestrated but are also active in synthesis and secretion. Endothelial cells of sinusoids and central veins secrete angiocrines that play respective roles in hepatic regeneration and metabolic homeostasis. The list of markers for identifying sinusoidal endothelial cells is long and their terminologies are complex. Further, their uses vary in different investigations and, in some instances, could be confusing. Central vein markers are fewer but more distinctive. Here we analyze and categorize the molecular pathways/modules associated with the sinusoid‐mediated liver regeneration in response to partial hepatectomy and chemical‐induced acute or chronic injury. Similarly, we highlight the findings that central vein‐derived angiocrines interact with Wnt/β‐catenin in perivenous hepatocytes to direct gene expression and maintain pericentral metabolic zonation. The proposal that perivenous hepatocytes behave as stem/progenitor cells to provoke hepatic homeostatic cell renewal is reevaluated and newer concepts of broad zonal distribution of hepatocyte proliferation in liver homeostasis and regeneration are updated. Thus, this review integrates the structures, biology and physiology of liver sinusoids and central veins in mediating hepatic regeneration and metabolic homeostasis.


  • The Hepatic Central Vein: Structure, Fibrosis, and Role in Liver Biology

    by Ki M. Mak, C. Y. Maximilian Png

    The hepatic central vein is a primary source of Wnt2, Wnt9b, and R‐spondin3. These angiocrines activate ß‐catenin signaling to regulate hepatic metabolic zonation and perivenous gene expression in mice. Little is known about the central vein ultrastructure. Here, we describe the morphological–functional correlates of the central vein and its draining and branching patterns. Central vein fibrosis occurs in liver disease and is often accompanied by perivenous perisinusoidal fibrosis, which may affect perivenous gene expression. We review the biological properties of perivenous hepatocytes and glutamine synthetase that serve as a biomarker of perivenous hepatocytes. Glutamine synthetase and P4502E1 are indicators of ß‐catenin activity in centrilobular liver injury and regeneration. The Wnt/ß‐catenin pathway is the master regulator of hepatic metabolic zonation and perivenous gene expression and is modulated by the R‐spondin‐LGR4/5‐ZNRF3/RNF43 module. We examined the structures of the molecules of these pathways and their involvements in liver biology. Central vein‐derived Wnts and R‐spondin3 participate in the cellular–molecular circuitry of the Wnt/ß‐catenin and R‐spondin‐LGR4/5‐ZNRF3/RNF43 module. The transport and secretion of lipidated Wnts in Wnt‐producing cells require Wntless protein. Secreted Wnts are carried on exosomes in the extracellular matrix to responder cells. The modes of release of Wnts and R‐spondin3 from central veins and their transit in the venular wall toward perivenous hepatocytes are unknown. We hypothesize that central vein fibrosis may impact perivenous gene expression. The proposal that the central vein constitutes an anatomical niche of perivenous stem cells that subserve homeostatic hepatic renewal still needs studies using additional mouse models for validation. Anat Rec, 2019. © 2019 American Association for Anatomy Anat Rec, 303:1747–1767, 2020. © 2019 American Association for Anatomy


  • Open Access

    The Hepatic Central Vein: Anatomical and Molecular Links to Perivenous Liver Biology

    by Ki Mark Mak

    The hepatic central vein, the initial branch of the hepatic veins, occupies the central position in the classic liver lobule. The endothelial cells of the vein contain organelles showing secretory modality and are supported by a thin wall containing collagenous matrix and a layer of myofibroblasts. Perivenous hepatocytes differ in ultrastructure from periportal heatocytes and stably express glutamine synthetase serving as a reliable biomarker. Central veins are a primary source of Wnt2, Wnt9b and R-spondin3. These angiocrines participate in the cellular-molecular circuitry of the Wnt/ß-catenin and R-spondin-LGR4/5-ZNRF3/RNF43 signaling modules associated with perivenous hepatocytes. These modules regulate hepatic metabolic zonation and perivenous gene expression. The structures of the molecules of these signaling pathways have been elucidated. Expression of glutamine synthetase and cytochrome P4502E1 is indicator of ß-catenin activity in liver injury and regeneration. The production, transport and secretion of lipidated Wnts in Wnt-producing cells and their passage in the extracellular matrix to contact responder cells have been described. The modes of Wnts and R-spondin3 release from cental vein endothelial cells and passage in the wall matrix to reach perivenous hepatocytes are unknown. GS+, Axin2+, Tbx3+, HNF4a+ and CPS- perivenous hepatocytes exhibit stem cell properties, subserving homeostatic hepatocyte renewal. The hepatic central vein constitutes an anatomical niche of perivenous hepatocyte stem cells and provides a molecular link to perivenous hepatic biology.